PreImplantation Factor (PIF) correlates with early mammalian embryo development-bovine and murine models
© Stamatkin et al; licensee BioMed Central Ltd. 2011
Received: 20 September 2010
Accepted: 15 May 2011
Published: 15 May 2011
PreImplantation Factor (PIF), a novel peptide secreted by viable embryos is essential for pregnancy: PIF modulates local immunity, promotes decidual pro-adhesion molecules and enhances trophoblast invasion. To determine the role of PIF in post-fertilization embryo development, we measured the peptide's concentration in the culture medium and tested endogenous PIF's potential trophic effects and direct interaction with the embryo.
Determine PIF levels in culture medium of multiple mouse and single bovine embryos cultured up to the blastocyst stage using PIF-ELISA. Examine the inhibitory effects of anti-PIF-monoclonal antibody (mAb) added to medium on cultured mouse embryos development. Test FITC-PIF uptake by cultured bovine blastocysts using fluorescent microscopy.
PIF levels in mouse embryo culture medium significantly increased from the morula to the blastocyst stage (ANOVA, P = 0.01). In contrast, atretic embryos medium was similar to the medium only control. Detectable - though low - PIF levels were secreted already by 2-cell stage mouse embryos. In single bovine IVF-derived embryos, PIF levels in medium at day 3 of culture were higher than non-cleaving embryos (control) (P = 0.01) and at day 7 were higher than day 3 (P = 0.03). In non-cleaving embryos culture medium was similar to medium alone (control). Anti-PIF-mAb added to mouse embryo cultures lowered blastocyst formation rate 3-fold in a dose-dependent manner (2-way contingency table, multiple groups, X2; P = 0.01) as compared with non-specific mouse mAb, and medium alone, control. FITC-PIF was taken-up by cultured bovine blastocysts, but not by scrambled FITC-PIF (control).
PIF is an early embryo viability marker that has a direct supportive role on embryo development in culture. PIF-ELISA use to assess IVF embryo quality prior to transfer is warranted. Overall, our data supports PIF's endogenous self sustaining role in embryo development and the utility of PIF- ELISA to detect viable embryos in a non-invasive manner.
The viable mammalian embryo controls its own destiny, transmitting specific signals to the mother/host throughout pregnancy : Within the uterus, such signals support implantation  while in the periphery they induce and/or maintain tolerance without allowing for deleterious immune suppression to occur . Evidently, acceptance signals by the mother also play an important role. Since the immune milieu of pregnancy is unique - not replicated in any other circumstances - specific embryo-derived signals have a crucial role leading to maternal recognition of pregnancy . To orchestrate such critical 'cross-talk', a viable embryo must be present, which may be accepted by the mother, whereas, a non-viable conceptus will fail to develop or later be rejected since maternal acceptance does not occur. The search to identify embryo-specific markers which reflect viability of cultured embryos by assessing the medium or by performing an embryo biopsy (beyond morphological evaluation) has been ongoing. However, thus far no marker has entered into routine clinical use in humans or other mammals undergoing IVF procedures [5, 6].
In humans, the platelet activating factor - (PAF)  and early pregnancy factor-(EPF)  have not been proven useful in selecting the best embryos for transfer to the recipient. Soluble HLA-G (sHLA-G) also failed to confirm its proposed utility in clinical studies . Measurement of free radicals in the culture medium of developing embryos has been reported as an index for embryo viability. However, it is not an embryo-specific marker and the fate of the transferred embryo cannot be followed in maternal circulation .
The Barnea group reported that viable mouse and human embryos secrete a peptide, PreImplantation Factor (PIF) (MVRIKPGSANKPSDD), which is present in maternal circulation and is expressed by embryos and placental tissue [4, 11–14]. In the placenta, PIF was found to be expressed in the trophoblastic layer in the first and second trimester while minimally being expressed at term as documented by staining using a specific anti-PIF-antibody . Synthetic PIF analog (sPIF) replicates native PIF action, modulates peripheral immune cells to achieve tolerance without immune suppression, and has been demonstrated to be effective in autoimmunity models outside pregnancy [15–17]. PIF displays essential multi-targeted effects; regulating immunity, promoting embryo-decidual adhesion, and regulating adaptive apoptotic processes in cultured human decidual cells . In addition, PIF promotes trophoblast invasion reflecting an autocrine supporting effect on conceptus development . We have previously demonstrated that PIF is secreted by viable embryos . Therefore, it is important to determine whether monitoring PIF levels in embryo culture medium could be of value in determining embryo developmental potential reaching to the blastocyst stage. Further, since PIF is an early secretory product, determining whether the peptide has embryo trophic effects could further substantiate its role in early pregnancy events.
Since access to large quantities of culture medium from human IVF embryos is limited (single embryos are cultured in low volumes), it was decided to examine PIF secretion into the medium using our ELISA methods in two different species offering complementary features. In mice, a large number of embryos can be cultured together which enables measurements of an expected low PIF level in the medium. Bovine embryos (larger size) can be successfully cultured singly to assess the source of PIF production by individual embryos. The single bovine embryo cultures serve as an IVF model where serial measurements of secreted products also can be determined.
The aims of the study were: 1. Determine PIF levels by ELISA in the medium of post-fertilization mouse embryos cultured up to the blastocyst stage. 2. Measure PIF levels by ELISA in the medium of cultured single bovine IVF embryos. 3. Test the inhibitory effect of anti-PIF-monoclonal antibody added to cultured mouse embryos. 4. Examine FITC-PIF uptake by cultured bovine blastocysts. We report that PIF is secreted by viable bovine and mouse embryos and we suggest that the peptide has a supporting role in embryo development.
Biotin-conjugated mouse anti-PIF mAb, (proprietary of BioIncept LLC) horseradish peroxidase (HRP)-conjugated streptavidin (UltraAvidin-HRP), antigen-coating buffer and tetramethylbenzidine (TMB) substrate were all obtained from Leinco Technologies, Inc. (Saint Louis, MO). SEA BLOCK blocking buffer was obtained from Thermo Scientific (Waltham, MA). LumiGLO Peroxidase Chemiluminescent substrate was obtained from KPL, Inc. (Gaithersburg, MD). Synthetic PIF (MVRIKPGSANKPSDD) and scrambled PIF (GRVDPSNKSMPKDIA) (proprietary of BioIncept LLC) were obtained by solid-phase peptide synthesis (Peptide Synthesizer, Applied Biosystems, Foster City, CA) using Fmoc (9-fluorenylmethoxycarbonyl) chemistry. The same peptides were also labeled with FITC on their N-termini in the solid phase after the addition of l-alanine as a spacer group. Final purification was conducted by reversed-phase HPLC and identity was verified by MALDI-TOF mass spectrometry and amino acid analysis. Ovalbumin-conjugated PIF was also generated. (Biosynthesis, Inc., Lewisville, TX).
Mouse embryo cultures
The study has been approved by Cari Research Institute. A routinely used mouse embryo culture procedure was used in this study [11, 12]. 2-cell embryos were collected from super ovulated mated CB6F1/J mice. Removed oviducts were dissected under microscope and embryos removed in mHTF medium (n = 10 to110/well) and cultured in using 4 well (176740) and 24 well (142475) Nunc well plates in 500 μl droplets of culture medium (5% Quinns advantage blastocyst medium, RM-ART-1029 in 95% mHTF), Cat No 90125 (Irvine Bio, CA) and 10% FBS under mineral oil by incubating at 37°C with 5% CO2 for 3 days, at a pH 7.2 which was maintained throughout the culture period. In the first set of experiments, mouse embryos were cultured serially from the morula stage (15 dishes with 10 morula each) to the blastocyst stage (15 dishes with 10 blastocysts each) and PIF levels were compared with atretic embryos (those embryos that degenerated and failed to progress beyond the 2-cell stage). (8 dishes with 10 embryos each) or culture medium alone, used as control. In the second set of experiments to determine how early PIF is secreted, 2-cell stage embryos (102-110/well) were collected and cultured up to 4 hours and then the medium was collected. In the third set of experiments embryos (10 to15/group) were cultured in 100 μl droplets for 72 hours up to the blastocyst stage and PIF levels in the medium were determined and compared with medium alone (control). The data were calculated as estimated amount total in culture as well as estimated by individual embryos.
In vitro fertilization procedure to retrieve bovine oocytes
The study has been approved by the Louisiana State University. At the Louisiana State University Embryo Biotechnology Laboratory, in vitro fertilization (IVF) was performed on bovine oocytes obtained from a commercial source (Ovitra, TX). Oocytes arrived in a climate controlled container via FedEx at ~24 hours following their collection. A standard bovine IVF laboratory procedure was performed on groups of 10 oocytes in 40 μl droplets of fertilization medium (IVF-TALP). Briefly, 2 μl of heparin (2 μg/ml), 2 μl of PHE and 2 μl sperm were added to each fertilization droplet with the M-II oocytes. This made the total medium volume 44 μl. Frozen-thawed sperm from a fertile Holstein bull was used in all bovine IVF experiments. The in vitro fertilization interval was 18 hours incubated in a humidified atmosphere of 5% CO2 in air at 39°C.
Following fertilization, the presumptive zygotes were removed from the fertilization droplets and treated with hyaluronidase (1 mg/ml) to remove the remaining cumulus cells. The embryos were then washed in HEPES-TALP medium and transferred to CR1aa medium . A single embryo from the group of IVF-derived embryos was then placed into a fresh 40 μl droplet of CR1aa culture medium at 39°C in a humidified atmosphere of 5% CO2 in air. On day 3 of culture, individual embryos were transferred to a new 40 μl droplet of CR1aa and incubated at 39°C in a humidified atmosphere of 5% CO2 in air and were cultured in the same medium until day 7 of culture. At the end of the experiment, embryos were assigned an embryo quality grade (1 = good to 3 = poor) and evaluated for morphological development (2-cell stage through to the blastocyst stage).
PIF secretion in IVF-derived bovine embryos during in vitro culture
IVF was performed on M-II bovine oocytes (n = 116). Following fertilization, single normal appearing zygotes were then placed into an individual 40 μl droplet of CR1aa culture medium  (n = 120). On day 3 of culture, embryos were transferred to a new 40 μl droplet of CR1aa medium for days 3 to 7 of in vitro culture. Only embryos that showed morphological development were transferred to fresh individual culture droplets. Morphological development of the embryos on days 1, 3 and 7 was recorded just prior to being moved to a fresh culture medium. After the embryos were moved from the 40 μl droplets, two 10 μl samples of conditioned culture medium from day 3 and day 7 culture were collected and frozen for subsequent determination of PIF concentrations using a PIF- ELISA described below.
Neutralize endogenous PIF using anti-PIF monoclonal antibody
An anti-PIF monoclonal antibody was developed (Genway, Inc. San Diego, CA.) and its specificity was subsequently validated (see ELISA methods). Mouse 2-cell stage embryos (n = 19-36/group) were cultured with increasing antibody concentrations (0.047-47 μg/ml). After culturing for 72 hours, the number of embryos that developed at each morphologic stage was recorded. Embryo quality and in vitro survival were evaluated from the 2-cell stage through the blastocyst stage. Also, the number of atretic embryos following exposure to each treatment was noted. These results were compared with exposure to the non-specific mouse anti-IgG isotype monoclonal antibody (Zymed, San Francisco, CA) that served as the negative control and culture medium alone that served as an additional control.
PIF-ELISA methods: sandwich PIF-ELISA
Affinity purified anti-PIF Ab (rabbit IgG, Covance Laboratories, PA) in bicarbonate buffer (pH 9.0) was diluted 1:2000 and 100 μl of the solution was added to 96 -well plates, incubated for 1 hour at 37°C and then refrigerated overnight at 4°C, then washed three times with PBS. Each plate was blocked with 100 μl 0.2% of nonfat dry milk in PBS and incubated for one hour at room temperature followed by washing with PBS. Either 50 μl mouse embryo culture medium or 50 μl PIF standards (0.007 to 1 μg/ml) was added to plates. Following 1 hour incubation, plates were washed with PBS. Then 100 μl of anti-PIF monoclonal antibody at 1:4000 in PBS was added and incubated for 1 hour followed by washing with PBS. 100 μl conjugated goat anti-mouse IgG alkaline phosphatase (Pierce, Rockford, IL) was added and incubated for 1 hour followed by washing with PBS. 100 μl substrate buffer (p-nitrophenyl) (Pierce) was added and the reaction was stopped after 15-20 minutes with 70 μl 3M NaOH. A standard curve is shown (see Additional file 1, Figure S1). Also the anti-PIF-monoclonal antibody properties that are provided comparing PIF binding as compared with scrambled PIF (no binding) (see Additional file 2, Figure S2). The affinity of anti-PIF-monoclonal antibody to PIF is shown (see Additional file 3, Figure S3). The serial mouse embryo culture data was generated with the sandwich assay.
Studies for FITC-PIF uptake by bovine blastocysts: Oocyte recovery and selection
The study has been approved by Cornell University College of Veterinary Medicine. Ovine ovaries were collected at nearby abattoir and transported to the laboratory in prewarmed lactated Ringer's solution at 30-35°C. Cumulus oocyte-complexes (COCs) from 2-8 mm follicles were aspirated with an 18G hypodermic needle attached to an aspiration pump unit adjusted to a pressure of 22.5 ± 2.5 ml of H2O per minute. Follicular fluid supernatant was removed and the pellet containing COCs was transferred to a 15 ml tube where it was resuspended with holding media and contents were poured gently into a 100 mm Petri dish. Holding media consisted on TCM-199 Hank's salts (Invitrogen ) 10% Fetal Calf Serum (Invitrogen), 25 μg/ml gentamicin and heparin 4 μg/ml (sigma) with a mOsm = 300 ± 1. Morphological selection of COCs consisted of using only those showing several layers of granulosal cumulus cells and oocytes with a homogenous cytoplasm.
In vitro maturation
Selected COCs were matured in groups of 40 ± 5 for 23 ± 1 hours in 400 μL of TCM-199 (Earle's Salts [Sigma M2154]) enriched with 10% fetal calf serum (FCS; Invitrogen), 22 μg/ml sodium pyruvate, 1 mM alanyl-glutamine, 0.1 mM taurine, 0.1 mM cysteamine, 1 μg/ml estradiol, 5 μg/ml luteinizing hormone (LH; SIOUX Biochemical, Inc., Sioux Center, IA), 0.5 μg/ml follicle stimulating hormone (FSH; SIOUX), 10 ng/ml epidermal growth factor (EGF; BD Biosciences--Discovery Labware, MA), 25 μg/ml gentamicin, pH 7.35 ± 2 and mOsm 300 ± 2 covered with mineral oil in a humidified atmosphere at 38.5°C with 5% CO2 in air.
In vitro fertilization
After a total of 23 ± 1 hours presumptive matured oocytes were transferred to a modified IVF medium (Fert-TALP)  supplemented with 0.5 mM fructose, 6 mg/ml BSA FFA Fraction V, 30 μM penicilamine, 15 μM hypotaurine, 1.5 μM epinephrine (PHE), 22 μg/ml heparin, covered with mineral oil in a humidified atmosphere at 38.5°C with 5% CO2 in air for 18-22 hours (pH of 7.38 ± 1, mOsm 290 ± 2). Frozen semen samples from a single bull were thawed and sperm was separated from the seminal plasma and cryoprotectant by percoll step gradient (90, 45%) centrifugation at 700 × g for 20 min. Subsequently, sperm was washed twice in 5 ml of TL-Semen (pH 7.39 ± 1, mOsm 295 ± 2) at 300 × g for 5 min to remove Percoll. Finally, sperm was adjusted to a final concentration of 1.5 × 106 sp/ml and with an average progressive motility of 50% using Fert-TALP media.
In vitro embryo culture
A modified synthetic oviductal fluid (SOF)  media was used for the in vitro embryo culture (pH 7.4 ± 1, mOsm 275 ± 5). After fertilization, putative zygotes were denuded at maximum vortex for 120 seconds and transferred to a modified SOF (SOF early) supplemented with 10 μM EDTA, 0.5 mM fructose, 4 mg/ml BSA FFA Fraction V, 0.1 mM taurine, and without essential amino acids covered with mineral oil in a humidified atmosphere at 38.5°C with 5% CO2, 5% O2, and 90% N2 in air for ~48 hours. After that time, cleavage rates were assessed and embryos were transferred to new droplets containing SOF mid, which was supplemented with essential and non-essential amino acids, 4 mg/ml BSA FFA Fraction V, and 0.5 mM glucose in a humidified atmosphere at 38.5°C with 5% CO2, 5% O2, and 90% N2 in air for ~96 hours. Embryos were transferred to fresh SOF mid droplets under the same conditions after the first ~48 hours. Finally, d-7 embryos were transferred for the last ~24 hours of culture to SOF late, which was SOF supplemented with 5% fetal calf serum (FCS), 0.1 mM taurine and 0.5 mM glucose in a humidified atmosphere at 38.5°C with 5% CO2, and 5% O2, and 90% N2 in air. Further, blastocyst rates were based on percentages of the original oocyte number.
FITC-PIF uptake by bovine blastocysts
After eight days post-fertilization, embryos were sorted by stage (i.e. blastocyst, expanded blastocyst and hatched blastocyst) (N = 23) and cultured for 30 minutes in synthetic oviductal media droplets containing 5 μg/ml FITC-PIF or FITC-PIFscrambled in a humidified atmosphere, 5% CO2, 5% O2 and balanced N2 with a temperature 38.5°C. Blastocysts were counterstained with DAPI (diamidino-2-phenylindole) a blue fluorescent probe that fluoresces brightly upon selectively binding to the minor groove of double stranded DNA, (nuclear) where its fluorescence is approximately 20-fold greater than in the non-bound state. Subsequently, blastocysts were washed in PBS/PVP solution to remove non-specific binding and fixed in 10% formalin containing 0.1% triton x-100. Fixed embryos were mounted on slides with two etched 10 mm diameter circles surrounded by white ceramic ink, embryos were covered with glycerol containing Hoechst 33348 (3 μg/ml).
All slides were visualized using a microscope (Imager Z1; Carl Zeiss, Inc.) under a 20 × 0.5 NA ECPlan Neofluar air immersion (Carl Zeiss, Inc.). The fluorochromes used FITC and nuclei were observed using DAPI filter. Slides were excited at 340 nm and 488 nm to visualize DAPI nuclear stain and FITC, respectively. Images were captured with a cooled charged-coupled device camera (AxioCam MRm; Carl Zeiss, Inc.) and processed using AxioVision software (version 4.7.2; Carl Zeiss, Inc.). Images untouched were taken as superimposed (FITC/DAPI), FITC and DAPI, alone.
PIF secretion by mouse embryo cultures and by cow embryos was analyzed by ANOVA followed by paired Student's t-test. The proportion of mice embryos that were affected by exposure to anti-PIF monoclonal antibody was determined using a 2-way contingency multi-group Chi square analysis. Analysis was carried out using Analyse-it for Microsoft Excel. A P < 0.05 level was considered to be significantly different in these studies.
PIF is secreted by viable embryos
PIF secretion starts at the 2-cell stage
PIF secretion by mouse embryos at day 0 and day 3 of culture
Mean +/-SEM 23.7+/-13.5
PIF is secreted by viable individual IVF derived embryos (bovine)
Endogenous PIF is a requirement for early embryo development
Anti-PIF-antibody reduces mouse embryos blastocyst development
Anti-PIF Mab Titration N =
AT > Morula
AT < Morula
FITC-PIF is being uptaken by cow blastocysts
PreImplantation Factor is secreted by viable embryos (absent in non-viable embryos) and has been reported to play an essential role in early pregnancy events: creating maternal tolerance and promoting embryo implantation starting shortly post-fertilization [18, 19]. We demonstrate herein that PIF is secreted by both viable mouse and bovine IVF embryos, indicating that the peptide may serve as a universal embryo viability marker. PIF secretion starts shortly post-fertilization, detected as early as the 2-cell stage, and reflects PIF's critical role in the earliest stages of mammalian embryo development. Neutralization of endogenous PIF effect reveals that the peptide is needed for embryos to progress to the blastocyst stage, since PIF exerts an obligatory direct supportive role. Hence, PIF-ELISA is an effective method to assess non-invasively the viability of cultured embryos at the earliest developmental stages and correlate PIF levels with their potential reaching the blastocyst stage. PIF-ELISA may thus represent a reliable tool to facilitate IVF embryo selection for transfer into the maternal host.
PIF was already detected at the 2-cell stage in mouse embryo culture medium. This confirms our previous results on PIF activity in both mouse and human embryo culture medium [14, 23]. However, as expected given the limited secretion by mouse embryos, PIF detection required large group of embryos to be cultured together. These results confirm the intimate involvement of PIF in embryo development since levels are higher in cultured blastocysts, as compared with morula. Thus, the increased peptide levels correlated with a more advanced developmental stage. In contrast, PIF was not detected in atretic embryo culture medium. Given the inherent murine model limitations, multiple embryos (due to low-level PIF production) were required to be cultured; which did not permit to establish individual embryos contribution of PIF secreted into the medium. To overcome this limitation, culturing single bovine IVF embryos enabled to directly correlate PIF levels (within the same embryo) with development up to the blastocyst stage. As expected, in failed bovine embryos, (those that degenerate), levels were similar to non-cleaving embryos alone (assay background levels).
From these findings, PIF emerges as an early, reliable, and non-invasive embryo-specific viability marker which could improve IVF success rates without the need to culture embryos up to the blastocyst stage before transfer to the maternal host. This is likely since in the models used, PIF levels in embryos were determined in sequential cultures. Thus, early detection of PIF predicted a further progress in embryo development. PIF-ELISA method is easy to implement and results are available in <3 hours. And the assay is highly specific since the antibody does not cross-react with scrambled PIF, and the monoclonal antibody is highly potent.
We view that the data from single bovine embryo culture provides the evidence that PIF secretion increases with developmental stage, and therefore implementation for human IVF setting may be valuable. Thereby, PIF-based testing could be a valuable marker for assessing embryo viability in the medium, reducing the need for multi-embryo transfer. Preliminary evidence in that respect has been recently generated in women using an anti-PIF antibody-based immunoassay where detection in singly cultured embryo culture medium correlated with live birth post-multiple embryo transfer. Also more recently, no pregnancy has resulted following the transfer of single PIF negative embryos in women following IVF [23, 24].
Since PIF is already secreted by the post-fertilization embryo, the possible role of the peptide in modulating its own development was also examined. It was found that endogenous PIF levels are directly associated with embryo viability since adding of anti-PIF-mAb to the medium at the 2-cell stage markedly inhibited mouse embryo development, leading most frequently to their demise. Therefore, embryo-secreted PIF likely exerts an supportive role on embryo development starting shortly post-fertilization.
Hence, in our view the embryo emerges as a semi-autonomic entity that operates within the maternal milieu and PIF plays an essential role in promoting this relative independence. This is especially relevant during the period when the embryo is surrounded by the zona pellucida that may limit the access of trophic agents from the maternal host. Since the expression of the majority of embryo-derived compounds is lower post-fertilization, it is remarkable that PIF would be secreted shortly post-fertilization and its expression will continue also throughout pregnancy . The use of a non-specific monoclonal antibody as negative control that failed to affect embryo survival, verified that the anti-PIF-mAb effect was specific.
The anti-PIF-mAb data raises the question: how does PIF exert its embryo-trophic effect and whether the effect is direct or indirect. We found that FITC-PIF is being taken-up by the cultured cow blastocyst, which implies the presence of an autocrine loop. This might also explain the data generated using anti-PIF-mAb to inhibit embryo development. Where a break in this autocrine loop (the secreted PIF is not being taken-up) has led to the arrested embryo development. The identification of endogenous sites within the embryo where PIF interacts is an active area of investigation. To document binding specificity, two different stains were performed. The DAPI stain documented that cells were intact and nucleus is well preserved. Then images were superimposed with FITC-PIF staining. The data showed progressive change in location of FITC-PIF as the blastocyst has expanded (polarization?). The finding that the labeled scrambled PIF failed to bind reflects PIF specificity. In addition, similar observations using FITC-PIF uptake in culture mouse blastocysts were observed where a similar polarization was observed. (unpublished). This suggests that in both species an autocrine loop is present, which may have a role in supporting embryo development shortly post-fertilization. Support for PIF's autocrine trophic role was recently documented in singly cultured bovine embryos when addition of sPIF for the first three days increased the number of embryos reaching up to the blastocyst stage at day 7 .
This study is limited although FITC-PIF binding to blastocysts was demonstrated, the specific sites of interaction were not precisely identified. Strengths of the research are the use of a specific sensitive monoclonal antibody-based PIF-ELISA that enables detection of low PIF levels and the use of two different mammalian species for embryo culture evaluation.
Previously, it was reported that culturing embryos in groups promote their development through a possible "cross talk". In addition, other possible supportive signals in embryos have been reported [26–30]. Our work clearly suggests that PIF has an important autocrine trophic cross-talk role.
In conclusion, endogenous PIF is required for embryo development and the supportive effects of the peptide are exerted directly on the embryo. Our observations add a novel facet for PIF secreted by the post-fertilization embryos; complementing the peptide's global role. Whereby, the embryo is controlling its own destiny by creating a favorable environment to enhance its development. PIF-ELISA is established as a valuable tool for PIF detection in culture medium of mammalian embryos reflecting on and correlating with their viability and progress to later stages of development and possible subsequent pregnancy success. The use of PIF measurements to improve embryo selection for transfer post-IVF is warranted and is currently being implemented in multicenter studies.
- Barnea ER, Coulam CB: Embryonic signals. Edited by: Jauniaux E, Barnea ER, Edwards R. 1997, Oxford Medical publication, 63-75.Google Scholar
- Aplin JD, Kimber SJ: Trophoblast-uterine interaction at implantation. Reprod Biol and Endocrinol. 2004Google Scholar
- Choudhury SR, Knapp LA: Human reproductive failure I: immunological factors. Hum Reprod Update. 2001, 7: 113-134. 10.1093/humupd/7.2.113.View ArticlePubMedGoogle Scholar
- Barnea ER: Insight into early pregnancy events: The emerging role of the embryo. Am J Reprod Immunol. 2004, 51: 319-322. 10.1111/j.1600-0897.2004.00159.x.View ArticlePubMedGoogle Scholar
- Barnea ER: Signaling between embryo and mother in early pregnancy: basis for development of tolerance. Edited by: Carp HJA. 2007, Recurrent Pregnancy Loss: Causes, Controversies and Treatment. Series in Maternal-Fetal Medicine. Informa Healthcare. Taylor & Francis Group publ, 2: 15-22.Google Scholar
- Devroey P, Fauser B, Diedrich K, Annual Reproduction (EVAR) Workshop Group 2008: Approaches to improve the diagnosis and management of infertility. Hum Reprod Update. 2009, 15: 391-408. 10.1093/humupd/dmp012.PubMed CentralView ArticlePubMedGoogle Scholar
- Minhas BS, Ripps BA, Zhu YP, Kim HN, Burwinkel TH, Gleicher N: Platelet activating factor and conception. Am J Reprod Immunol. 1996, 35: 267-71.View ArticlePubMedGoogle Scholar
- Cavanagh AC: The purification of early-pregnancy factor to homogeneity from human platelets and identification as Chaperonin 10. Eur J Biochem. 1994, 222: 551-60-3. 10.1111/j.1432-1033.1994.tb18897.x.View ArticlePubMedGoogle Scholar
- Tabiasco J, Al E: Soluble HLA-G in IVF/ICSI embryo culture supernatants does not always predict implantation success: A multicentre study. Reprod Biomed Online. 2009, 18: 374-81. 10.1016/S1472-6483(10)60096-X.View ArticlePubMedGoogle Scholar
- Seli E, Vergouw CG, Morita H, Botros L, Roos P, Lambalk CB, Yamashita N, Kato O, Sakkas D: Noninvasive metabolomic profiling as an adjunct to morphology for noninvasive embryo assessment in women undergoing single embryo transfer. Fertil Steril. 2010, 94: 535-42. 10.1016/j.fertnstert.2009.03.078.View ArticlePubMedGoogle Scholar
- Roussev RG, Coulam CB, Kaider BD, Yarkoni M, Leavis PC, Barnea ER: Embryonic origin of PreImplantation Factor (PIF): biological activity and partial characterization. Mol Human Reprod. 1996, 2: 883-887. 10.1093/molehr/2.11.883.View ArticleGoogle Scholar
- Barnea ER, Simon J, Levine SP, Coulam CB, Taliadouros G, Leavis P: Progress in characterization of PreImplantation Factor in embryo cultures and in vivo. Am J Reprod Immunol. 1999, 42: 95-99.PubMedGoogle Scholar
- Barnea ER, Sharma S: Prediction of Implantation in ART using molecular biology I. Infertility, Art & Endoscopy. Edited by: Allahbadia GN, Merchant R. 2006, Elsevier Pub, 183-194.Google Scholar
- Barnea ER, Perez R, Leavis PC: Assays for PreImplantation Factor and PreImplantation Factor peptides. USPTO 7,273,708 B2. 2007Google Scholar
- Barnea ER: Applying embryo-derived immune tolerance to the treatment of immune disorders. Ann N Y Acad Sci. 2007, 1110: 602-618. 10.1196/annals.1423.064.View ArticlePubMedGoogle Scholar
- Than NG, Paidas MJ, Mizutani S, Sharma S, Padbury J, Barnea ER: Embryo-placento-maternal interaction and biomarkers: from diagnosis to therapy--a workshop report. Placenta. 2007, 28 (Suppl A): S107-10. Epub 2007 Mar 23PubMed CentralView ArticlePubMedGoogle Scholar
- Lola Weiss Weiss, Bernstein S, Jones R, Amunugama R, Krizman D, JeBailey L, Almogi-Hazan O, Yekhtin Z, Shainer R, Reibstein I, Triche E, Slavin S, Or R, Barnea ER: PreImplantation Factor (PIF) analog prevents type I diabetes mellitus (TIDM) development by preserving pancreatic function in NOD mice. Endocrine. 2011,Google Scholar
- Paidas M, Krikun G, Haung J, Jones R, Romano M, Annunziato J, Barnea ER: Genomic and proteomic investigation of PreImplantation Factor's impact on human decidual cells. Am J Obstet & Gynecol. 2010, 202 (459): e1-8.Google Scholar
- Duzyj CM, Barnea ER, Li M, Huang J, Krikun G, Paidas MJ: PreImplantation Factor promotes first trimester trophoblast invasion. Am J Obstet & Gynecol. 203 (402): e1-4. Epub 2010 Aug 12
- Siranar MA, Parrish JJ, Ware CB, Leibfried-Rutledge ML, First NL: The culture of bovine oocytes to obtain developmentally competent embryos. Biol Reprod. 1988, 39 (3): 546-52. 10.1095/biolreprod39.3.546.View ArticleGoogle Scholar
- Rosenkrans CF, First NL: Effect of free amino acids and vitamins on cleavage and developmental rate of bovine zygotes in vitro. J Anim Sci. 1994, 72: 434-7.PubMedGoogle Scholar
- Holm P, Booth PJ, Schmidt MH, Greve T, Callesen H: High bovine blastocyst development in a static in vitro production system using SOFaa medium supplemented with sodium citrate and myo-inositol with or without serum-proteins. Theriogenology. 1999, 52 (4): 683-700. 10.1016/S0093-691X(99)00162-4.View ArticlePubMedGoogle Scholar
- Promponas EM, Keramitsoglou Th, Varla-Leftherioti M, Ramu S, Moschandreou D, Pantos Kf, Vaxevanoglou T, Bathrelos N, Koussoulakos S, Margaritis LΗ, Barnea ER: PreImplantation Factor (PIF*): non-invasive biomarker for embryo selection for In Vitro fertilization. (abstract). J Reprod Immunol. 2009, 81: 159-10.1016/j.jri.2009.06.223.View ArticleGoogle Scholar
- Mentorou C, Promponas EM, Keramitsoglou Th, Daves S, Mastrominas M, Perros G, Tzonis P, Diakakis I, Varla-Leftherioti M, Barnea ER: PreImplantation Factor (PIF*) levels in embryo culture supernatants after single embryo transfer correlate with pregnancy outcome. (Abstract ESRI, Munich 2010)
- Barnea ER, Stamatkin CW, Roussev RG, Stout M, Coulam CB, Triche E: PreImplantation Factor (PIF*) negates embryo toxicity and promotes embryo development in culture. RBMO. 2011,Google Scholar
- Brinson DR: Apoptosis in mammalian preimplantation embryos: regulation by survival factors. Hum Fert. 2000, 3: 36-47. 10.1080/1464727002000198671.View ArticleGoogle Scholar
- Gopichandran N, Leese HJ: The effect of paracrine/autocrine interactions on the in vitro culture of bovine preimplantation embryos. Reproduction. 2006, 131: 269-277. 10.1530/rep.1.00677.View ArticlePubMedGoogle Scholar
- Teruel MT, Catalano RC, Cabodevila JA, Callejas SS: Regulation of mouse embryo development by autocrine trophic factors. Biocell. 2005, 29: 183-186.PubMedGoogle Scholar
- Stokes PJ, Abeydeera LR, Leese HJ: Development of porcine embryos in vivo and in vitro; evidence for embryo 'cross talk' in vitro. Dev Biol. 2005, 284: 62-71. 10.1016/j.ydbio.2005.05.001.View ArticlePubMedGoogle Scholar
- Contramaestre AP, Sifontes F, Marín R, Camejo MI: Secretion of stem cell factor and granulocyte-macrophage colony-stimulating factor by mouse embryos in culture: influence of group culture. Zygote. 2008, 26: 1-5.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.